Drug intelligence / Profile preview

RLA01

Development stage
Preclinical
Modality
RNA Aptamers → RNA Therapeutics → Nucleic Acid Therapeutics, DNA Aptamers → DNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous
01

Overview

RLA01 is a single-stranded DNA (ssDNA) aptamer identified through cell-SELEX (Systematic Evolution of Ligands by Exponential Enrichment) for its high affinity and specificity toward epithelial ovarian cancer (EOC) cells. It functions as a targeting ligand that recognizes and binds to surface receptors overexpressed on EOC cells, such as the Caov-3 line, subsequently triggering receptor-mediated endocytosis. In preclinical research, RLA01 is frequently utilized to functionalize drug delivery vehicles, such as poly(lactic-co-glycolic acid) (PLGA) nanoparticles, to selectively deliver cytotoxic payloads like paclitaxel directly into tumor cells. This targeted approach aims to enhance the therapeutic index of chemotherapy by increasing intratumoral drug concentration while minimizing cellular uptake in non-target tissues, such as human ovarian surface epithelial (HOSE) cells.

Other names
RLA01 aptamerRLA-01 aptamerRLA 01 aptamer
02

Targets

FOLR1 (FRα)

Beyond the preview

Go deeper on RLA01.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RLA01.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call